A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study

BACKGROUND: Venous thromboembolism is common in patients with cancer and requires anticoagulation with low molecular weight heparin. Current data informs anticoagulation as far as six months, yet guidelines recommend anticoagulation beyond six months in patients who have locally advanced or metastat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Smith, Joanna D, Baillie, Jessica, Baglin, Trevor, Griffiths, Gareth O, Casbard, Angela, Cohen, David, Fitzmaurice, David A, Hood, Kerenza, Rose, Peter, Cohen, Alexander T, Johnson, Miriam, Maraveyas, Anthony, Bell, John, Toone, Harold, Nelson, Annmarie, Noble, Simon I
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4003288/
https://ncbi.nlm.nih.gov/pubmed/24726032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-122
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados